POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy. | LitMetric

POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.

Yan-Xing Chen Zi-Xian Wang Shu-Qiang Yuan Teng-Jia Jiang You-Sheng Huang Rui-Hua Xu Feng Wang Qi Zhao

Clin Transl Med

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, China.

Published: September 2021

Download full-text PDF
Source

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473642 PMC
http://dx.doi.org/10.1002/ctm2.524 DOI Listing

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473642	PMC
http://dx.doi.org/10.1002/ctm2.524	DOI Listing

Publication Analysis

Top Keywords

pole/pold1 mutation

mutation non-exonuclease

non-exonuclease domain

domain matters

matters predicting

predicting efficacy

efficacy immune-checkpoint-inhibitor

immune-checkpoint-inhibitor therapy

pole/pold1

non-exonuclease

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!